Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Limiroli, E.
Right arrow Articles by Sacerdote, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limiroli, E.
Right arrow Articles by Sacerdote, P.
(Journal of Leukocyte Biology. 2002;72:43-48.)
© 2002 by Society for Leukocyte Biology

Differential morphine tolerance development in the modulation of macrophage cytokine production in mice

Elena Limiroli, Leda Gaspani, Alberto E. Panerai and Paola Sacerdote

Department of Pharmacology, University of Milano, Italy

Correspondence: Paola Sacerdote, Dept. of Pharmacology, University of Milano, via Vanvitelli 32, 20129 Milano, Italy. E-mail: paola.sacerdote{at}unimi.it

Morphine has been shown to affect cell-mediated and humoral immune parameters. In this study, we investigated the capacity of in vivo acute and chronic morphine treatment to modulate interleukin (IL)-10 and IL-12 production by LPS and interferon-{gamma}-stimulated resident and thioglycollate-elicited murine peritoneal macrophages and the development of tolerance to these effects. One hour after the acute administration of 5, 10, and 20 mg/Kg morphine, a dose-related decrease of IL-10 and IL-12 levels was present. The pretreatment with naltrexone at doses up to 20 mg/Kg did not prevent the decrease of IL-10 and IL-12 induced by morphine. When the drug was administered chronically, a differential development of tolerance to the immune effects was observed. After 3 days of treatment, the effect of the acute challenge with 20 mg/Kg morphine on IL-12 was lost. In contrast, morphine-induced inhibition of IL-10 disappeared between 10 and 12 days of treatment, in parallel with tolerance to the antinociceptive effect. These results suggest that morphine treatment affects macrophage cytokine production and that tolerance affects this modulation differently.

Key Words: IL-10 • IL-12 • antinociception • naltrexone • TNF-{alpha}




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
C. Martucci, S. Franchi, D. Lattuada, A. E. Panerai, and P. Sacerdote
Differential involvement of RelB in morphine-induced modulation of chemotaxis, NO, and cytokine production in murine macrophages and lymphocytes
J. Leukoc. Biol., January 1, 2007; 81(1): 344 - 354.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
P. Sacerdote
Opioids and the immune system
Palliative Medicine, January 1, 2006; 20(8_suppl): 9 - 15.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
H. Beloeil, K. Asehnoune, P. Moine, D. Benhamou, and J.-X. Mazoit
Bupivacaine's Action on the Carrageenan-Induced Inflammatory Response in Mice: Cytokine Production by Leukocytes After Ex-Vivo Stimulation
Anesth. Analg., April 1, 2005; 100(4): 1081 - 1086.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. C. Alonzo and B. M. Bayer
Antagonism of N-Methyl-D-aspartate Receptors Reduces the Vulnerability of the Immune System to Stress after Chronic Morphine
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 793 - 800.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Leukocyte Biology.